ISDA

Deposition Date 2009-04-30

Release Date 2009-10-13

Last Version Date 2023-09-06

Entry Detail

PDB ID:

3H98

Keywords:

TRANSFERASE

Title:

Crystal structure of HCV NS5b 1b with (1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl) azolo[1,5-a]pyrimidine derivative

Biological Source:

Source Organism:

Hepatitis C virus (isolate BK) (Taxon ID: 11105)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.90 Å

R-Value Free:

0.27

R-Value Work:

0.20

R-Value Observed:

0.21

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:RNA-directed RNA polymerase
Chain IDs:A, B
Chain Length:576
Number of Molecules:2
Biological Source:Hepatitis C virus (isolate BK)

UniProt ID:P26663 Pfam ID:PF00998 EC:3.4.21.98

Ligand Molecules

B5P

GOL

Primary Citation

HCV NS5B polymerase inhibitors 2: Synthesis and in vitro activity of (1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl) azolo[1,5-a]pyridine and azolo[1,5-a]pyrimidine derivatives.

Wang, G, Lei, H, Wang, X, Das, D, Hong, J, Mackinnon, C.H, Coulter, T.S, Montalbetti, C.A, Mears, R, Gai, X, Bailey, S.E, Ruhrmund, D, Hooi, L, Misialek, S, Rajagopalan, P.T, Cheng, R.K, Barker, J.J, Felicetti, B, Schonfeld, D.L, Stoycheva, A, Buckman, B.O, Kossen, K, Seiwert, S.D, Beigelman, L.Show

Bioorg.Med.Chem.Lett. 19 4480 4483 (2009)

PMID: 19500983 DOI: 10.1016/j.bmcl.2009.05.022

Abstact

(1,1-Dioxo-2H-[1,2,4]benzothiadiazin-3-yl) azolo[1,5-a]pyridine and azolo[1,5-a]pyrimidine derivatives have been investigated as potential anti-HCV drugs. Their synthesis, HCV NS5B polymerase inhibition, and replicon activity are discussed.

Legend

Protein

Chemical

Disease

Primary Citation of related structures